PhaseBio Pharmaceuticals, Inc. (PHAS)

Depreciation & Amortization

$1.94M

TTM · Period ending: · USD

PHAS logo

PHAS Depreciation & Amortization

Latest reported$1.94M
PHAS TTM Depreciation & Amortization ($110.00K → $1.94M)
High-resolution chart · PNG

PHAS depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

PhaseBio Pharmaceuticals, Inc. Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
1,940,000
1,920,000
1,793,000
1,529,000
1,454,000
928,000
508,000
216,000
211,000
197,000
174,000
147,000
125,000
109,000
105,000
110,000
110,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.